MAPK3 and prostate cancer: P2 receptors are found in cervical, gastrointestinal, liver carcinoma, and prostate cancer cells and can activate esophageal cancer cell proliferation via the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway [16–22].